InvestorsHub Logo
Followers 789
Posts 39077
Boards Moderated 15
Alias Born 06/20/2009

Re: None

Wednesday, 11/11/2009 12:09:39 PM

Wednesday, November 11, 2009 12:09:39 PM

Post# of 52074
MZEI ON HIGH ALERT, DD HERE:

is a research and development company engaged in developing its
AsepticSure(TM) technology to decontaminate and sterilize hospital
surgical suites, emergency rooms, intensive care units, schools and
other critical infrastructure.

Perhaps some of you caught this post when it was @ .14

Post Date: 11/6/2009 9:27:31 AM
Board: Chrissy's Profit Palace

biotechs to watch:

AVXT, MZEI

If you did "watch" you surely then saw this post:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43409389

The stock has since made an extremely bullish move from .14 to .19 as
of this writing @ 10:40am and I simply can't keep this to myself any
longer as I think we are on the cusp of something truly special...

link to the MZEI board:
http://investorshub.advfn.com/boards/board.aspx?board_id=103


5 week volume average comparison... for the period from 8/31-10/2
MZEI traded an average of 966,920 shares per week in which the the
share price ranged from .08-.10 (obviously a very tight range), the
period that followed, from 10/5-11/6 saw a 139% increase in average
weekly volume to 2,316,680 shares per week in which the the share
price ranged from .07-.16 (with a close on 11/6 @ .16)

Medizone Consultants
Dr. Ronald K. St. John--As a board-certified physician in preventive
medicine, with post-graduate training in internal medicine, infectious
diseases, and public health, Dr. St. John has 35 years of experience
in the management of medical science for public health programs,
legislation, and policy development. During his career, he has
developed and managed large and small scale infectious disease control
programs in domestic and international environments. Shortly before
the 9/11 attacks in the US, he was appointed as a Director-General in
the Canadian Department of Health with responsibility for developing
Canada’s first Centre for Emergency Preparedness and Response for
crises and disasters affecting the health of the public. He retired
from this position in February 2007.

Dr. St. John began his public health career as a commissioned officer
in the US Public Health Service, assigned to the US Centers for
Diseased Control and Prevention. Through his work in domestic and
international organizations, he acquired an extensive understanding of
US Public Health Service institutions, the US and Canadian governments
and their states, provinces and territories, the Pan American Health
Organization (The World Health Organization's Regional Office for the
Americas), the World Health Organization and domestic and
international non-governmental and development organizations.

During his tenure with the Canadian Department of Health and
subsequently the Public Health Agency of Canada, he rebuilt the
Canadian Quarantine Service, co-founded the Global Public Health
Intelligence Network (GPHIN - a 24/7 global electronic monitoring
system of all infectious disease outbreaks worldwide), modernized the
Canadian National Emergency Stockpile System (a national network of
strategically placed depots containing emergency medical supplies
worth over $300 M) and established the first federal focus for medical
counter-terrorism.

Dr. St. John graduated from three distinguished Ivy League
Universities (BA from Yale University, MD degree from Columbia
University and Masters in Public Health from Harvard University).

Dr. Dick Eric Zoutman
Professor and Chair,
Divisions of Medical Microbiology and of Infectious Diseases, Queen's University
Medical Director of Infection Prevention and Control Services,
University Hospitals Kingston, Kingston, Ontario--Dr. Dick Zoutman has
been practicing medicine for over 20 years and specializes in Internal
Medicine, Infectious Diseases and Medical Microbiology at Queen's
University at Kingston. A primary focus of his investigative work has
been understanding the prevention and control of healthcare-associated
infections and related medical errors. Using a systems analysis
approach to examine healthcare operations, Dr. Zoutman has evaluated
antibiotic prescribing and utilization in the community, acute care
and long term care sectors. He has shed light on the factors that lead
to the over-prescribing of antibiotics in family practice, as well as
the failure of hospitals to successfully prevent surgical wound
infections by properly prescribing antibiotics to patients undergoing
major surgery. Dr. Zoutman continues to examine the impact of hospital
resource allocation and infectious adverse events, as well as the use
of information systems to improve the quality of patient care and to
reduce hospital acquired infections. Dr. Zoutman's work and
collaborations have spanned the globe from North America, South
America, the Balkans, the Middle East and Africa.

He is Physician-Director of the Board of the Community and Hospital
Infection Control Association of Canada. During the 2003 outbreak of
SARS in Toronto Dr. Zoutman chaired the Ontario SARS Scientific
Advisory Committee responsible for advising the Ontario government on
outbreak management strategies.

Dr. Zoutman is Chair of the National Bioterrorism Contingency Task
Force for Hospitals; and a member of the Infection Control Guidelines
Steering Committee and the Canadian Nosocomial Infection Surveillance
Program. Dr. Zoutman is also Chief of the Department of Medical
Microbiology and Medical Director of Infection Prevention and Control
at the South Eastern Ontario Health Sciences Center in Kingston. Dr.
Zoutman is professor of Pathology & Molecular Medicine, of Community
Health and Epidemiology, and of Medicine in the Faculty of Health
Sciences at Queen's University.

Development Team:
Dr. Michael E. Shannon
Dr. Dick Eric Zoutman
Gunter Moldzio-- C.E.O. of Biozone
Bernard Lim-- JTL Global Ventures (he usually commands $3,000 a day
for his consulting services but Medizone has negotiated to compensate
him $1,000 a day and he has exercisable options for when the company
reaches various stages of it's business model, for instance 500,000
shares exercisable when beta testing starts... why is so sure it's
going to start? Seems pretty confident in Medizone)
Dr. David Barnes
Robert Hirons-- Cohspat Corp.
Brad Goble-- TDV Global
Brady Allin-- TDV Global

(I implore you to google/research/whatever you do to do DD all of the
above names and tell me if you can find a red flag because I can't,
and trust me, I tried...)

As for the leader of the clan? A fearless one:
Edwin G. Marshall - Chairman of the Board and Chief Executive Officer

Mr. Marshall has served as Chairman of the Board since June, 1997 and
Chief Executive Officer since March, 1998.

Mr. Marshall attended Santa Rosa Community College and the College of
Marin, studying fire science and business administration. Until 1978
Mr. Marshall worked in the fire service in a city with a major
chemical industrial complex, leaving with the rank of Captain. He was
a successful private investor in precious metals, securities and real
estate and workeed in the real estate brokerage business pursuing
from 1978 until 1995 various business interests including the real
estate brokerage, a vacuum forming business in the plastics industry,
an industrial computer controls company, and an automobile and truck
dealership.

Since 1997 he has devoted all of his business time to management
responsibilities with Medizone.

(furthermore, what the website does not mention is how Marhsall came
to be c.e.o.... After being a large shareholder of MZEI in the 90's he
began to get fed up with management at the time as he felt that the
c.e.o. had been pocketing money from shareholders instead of putting
it to use with the company. What did he do? Went to the state's
attorney and asked if he could prosecute him, the state's attorney
told him he couldn't because the case was to small. Well, being the
ambitious work horse Ed is, he built the case HIMSELF, and as I
understand brought 2 very thick manilla folders back to the state's
attorney and asked him once more if he could prosecute the guy. The
state's attorney, impressed with the fact Ed took did all the work on
his own took up the case and the sucker did 5 years time and repaid
shareholders upwards of $400,000. That's the type of guy Ed is. Then
in the the middle of the 2000's he was approached by a couple
shareholders who said they would fund $2,000,000 privately to the
company if Ed would just do a reverse split and try and help get
things moving. Ed made a point to say that the company was closer to
going under than it was proceeding with operations at the time of this
proposal. read below)
___________________________________________________________________________________________________
THE SAND DOLLAR SOLUTION
144 BUENA VISTA
P.O. BOX 742
STINSON BEACH, CALIFORNIA 94970

May 6, 1997


My Fellow Medizone International, Inc. Shareholder's,


I believe a moment of truth and opportunity is before you. Our Company
is in a desperate situation. Current management, led by Joseph Latino for the
previous three years, has failed to fund or manage Medizone in a viable manner.
At this time, Medizone is financially insolvent. Research is not progressing and
three Board members: Larry Sosnow, Richard Solomon, and Howard Feinsand have all
resigned in the previous seven months. A fourth, Ken Gropper, has threatened
resignation if the resignation or firing of Joseph Latino is not achieved.

In our view Medizone is not only dysfunctional, for all practical
purposes it is a non-entity. When Joseph Latino became President of Medizone the
stock was trading at approximately $0.32 per share. Today it is trading just
above $0.05.

The enclosed proxy, which I strongly ask you to support, offers the
opportunity to elect four very qualified members to the Board, as well as to
approve a financing package that is above current market prices. These changes
will allow us to install new and professional management, begin a positive
corporate direction and once again advance the science.

Milton Adair will lead the new management team and will personally
select a new CEO from the applicants we are currently reviewing. Milton brings a
35 year business background in the bio-tech industry. His leadership strengths
vary from sales and marketing to product development and FDA relations.

Gerard Sunnen, M.D. has been involved with Medizone for over 10 years.
He first studied the use of ozone in Germany in 1986. A published ozone
researcher, Dr. Sunnen has strong professional ties in Europe. He will be an
excellent liaison for Medizone with the Italian researchers, without needing an
interpreter.

William Hitt, M.D. brings a renowned background. A long time member of
The World Health Organization, and recipient of the prestigious Eli Lily award
for his discovery and report of new anaerobic species of mycoplasma, Dr. Hitt
has not only instructed immunology at both John Hopkins University and Louisiana
State University he brings research and business expertise to the Board as well.

The strongest remark I can make about my own qualifications is that I
have been able to formulate this plan, form Sand Dollar Solution, a financial
arm of this endeavor, and bring these

distinguished people together. There is no doubt in my mind we will succeed. We
do ask your timely support in order to accomplish this.

Richard Solomon, a former Board Member and Director of Medizone New
Zealand was asked to join this effort. While he declined to be a candidate for a
Board seat at this time, he did pledge his full support to these efforts, and
gave us permission to use his name. With his background and knowledge as a Board
Member up until February 27 of this year, Richard is well aware of the
challenges we face, and will be of vital help to the new management team.

As you review the proxy, particularly the section entitled, "Sand
Dollar's Complaints Concerning Management", I believe you will see what grave
circumstances the company is in. My personal evaluation is that the Company is
currently not in a survivable situation. Please help us change that.

I strongly urge you to carefully read the proxy and carefully fill out
the proxy card to insure we will be able to count your vote. Your company is at
stake. Please follow through with this proxy request immediately.

I thank you very much for your support, without which, these efforts
would be futile.

YOURS TRULY,




EDWIN G. MARSHALL,
BOARD NOMINEE
FOUNDER, MEDIZONE SHAREHOLDER'S GROUP
MANAGING AND GENERAL PARTNER,
THE SAND DOLLAR SOLUTION,
A CALIFORNIA LIMITED PARTNERSHIP
___________________________________________________________________________________________________


some recent s.e.c. filings to take note of:

Form S-8 - Securities to be offered to employees in employee benefit plans:
http://sec.gov/Archives/edgar/data/753772/000117935009000069/0001179350-09-000069-index.htm

Form 10-Q - Quarterly report:
http://sec.gov/Archives/edgar/data/753772/000117935009000054/0001179350-09-000054-index.htm

Please do look over those, and look over the many reports they have
filed (which include PR's as well):
http://sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000753772&type=&dateb=&owner=exclude&start=0&count=40

useful links:
management team w/profiles--
http://medizoneint.org/medizone-international-inc-otc-mzei/management/
research:
http://medizoneint.org/asepticsure™/research/
corporate strategy:
http://medizoneint.org/medizone-international-inc-otc-mzei/our-strategy/

2009 press releases:
http://medizoneint.org/investor-relations/shareholder-communications/november-10-2009-mrsa-breakthrough-announced-for-asepticsure™-hospital-sterilization-system/
http://medizoneint.org/investor-relations/shareholder-communications/sept-8-2009-medizone-international-inc-announces-otcbb-listing/
http://medizoneint.org/investor-relations/shareholder-communications/august-5-2009-medizone-expects-otcbb-listing/
http://medizoneint.org/investor-relations/shareholder-communications/july-13-2009-medizone-international-inc-has-filed-for-patent-protection-for-asepticsure-hospital-sterilization-system/
http://medizoneint.org/investor-relations/shareholder-communications/july-7-2009-medizone-international-inc-announces-it-has-established-its-own-bsl2a-certified-laboratory-located-in-innovation-park-queens-university-at-kingston-ontario-canada/

2008 press releases:
http://medizoneint.org/investor-relations/shareholder-communications-2008/san-franciscocalifornia-november-4-2008-medizone-international-inc-mzei-pk-announces-consulting-relationship-with-tdv-global-inc/
http://medizoneint.org/investor-relations/shareholder-communications-2008/oct-30-2008-medizone-international-inc-establishment-of-canadian-foundation-for-global-health/
http://medizoneint.org/investor-relations/shareholder-communications-2008/oct-1-2008-medizone-international-inc-mzei-pk-announces-hospital-sterilization-initiative/
http://medizoneint.org/investor-relations/shareholder-communications-2008/september-26-2008-medizone-international-appoints-equiti-trends-advisors-as-shareholder-relations-firm/
http://medizoneint.org/investor-relations/shareholder-communications-2008/medizone-international-inc-appoint-dr-michael-shannot-to-board-of-directors/

(These guys do not put out fluff PR's, but you already know that
because you just read every press release)

2009 annual shareholder meeting:
http://medizoneint.org/news-and-events/579/

POWERPOINT MUST SEE!!!
http://sec.gov/Archives/edgar/data/753772/000109690609001058/mzei8k20090826ex99.htm
_______________________________________________________________________________________

Guys and Gals, I cannot pound the table harder and say that NOW IS THE
TIME TO BE APART OF SOMETHING TRULY SPECIAL! Medizone has a product
the market needs, I can tell you personally, having several family
members in the medical field, they are ALL impressed and optimistic
with what Medizone hopes to achieve. I spoke with Mr. Marhsall
extensively on Monday (11/9) and he told me that he felt shareholders
would have reason to be VERY excited very soon, little did I know that
meant a press release was coming out today. For all who haven't seen
it, you must:

http://ih.advfn.com/p.php?pid=nmona&article=40291110&symbol=MZEI

"Current trials are now being expanded to include a hospital mock-up
to be followed by hospital beta testing. Initial sales are targeted to
commence early in 2010."

There's at least 3 juicy PR's right there... not to mention Ed told me
they would by filing Q3'09 by the "end of the week."

Do your own DD as always, I think when you do you will realize this is
not your average pick. As always take profits when appropriate but I'm
telling you now, if everything falls into place this stock will change
lives, both financially and physically. If you think I'm joking, just
watch what happens over the coming months/years...

Pisa & Sky

(please note: this is the first INTIAL DD report that is to going to be followed up with MULTIPLE posts digging deeper and deeper into MZEI)


here's some posts I think people should take the time to read:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43435866
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43435770
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43428747
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=43427746

NOT TO GO UNNOTICED:

These guys file with the S.E.C. regularly and I am told we have another one coming;

http://sec.gov/cgi-bin/browse-edgar?company=medizone+international&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Visit my favorite board, Chrissy's Profit Palace for a wealth of knowledge & the knowledge of wealth!
http://investorshub.advfn.com/boards/board.aspx?board_id=16192

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.